Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Screening at centre of Angola's Marburg efforts:

This article was originally published in Clinica

Executive Summary

Screening units are being set up in Angola to improve the early diagnosis of Marburg haemorrhagic fever and ensure the isolation of infected cases. An isolation ward in a 400-bed hospital, the largest in Uige province, which accounts for 90% of cases to date, has been specially equipped to handle Marburg. All patients admitted are being screened for the disease. The World Health Organization has also begun a programme of training in the use of equipment and supplies, with the aim of reducing the risk of transmission in the healthcare setting. The disease had claimed at least 215 lives among the 235 cases confirmed up to April 12, reports the WHO.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel